Table 3. The associations between plasma miRNA levels over time with patient characteristics.
miR125b† |
miR141† |
miR16† |
miR17-3p† |
miR200b† |
miR29a† |
miR31† |
miR92a† |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Estimate§ (95% CI) | P-val | Estimate (95% CI) | P-val | Estimate (95% CI) | P-val | Estimate (95% CI) | P-val | Estimate (95% CI) | P-val | Estimate (95% CI) | P-val | Estimate (95% CI) | P-val | Estimate (95% CI) | P-val | |
Intercept | 10.54 (9.68, 11.4) | 9.5 (7.03, 11.96) | 15.38 (14.62, 16.13) | 8.96 (7.95, 9.96) | 9.65 (8.26, 11.03) | 13.59 (12.75, 14.43) | 8.56 (7.57, 9.56) | 15.81 (14.95, 16.66) | ||||||||
Age | 0.03 | 0.19 | 0.13 | 0.09 | 0.08 | 0.26 | 0.40 | 0.28 | ||||||||
⩾56 | −0.45 (−0.87, −0.04) | 0.93 (−0.66, 2.52) | −0.29 (−0.66, 0.09) | −0.44 (−0.93, 0.06) | −0.62 (−1.32, 0.07) | −0.24 (−0.65, 0.18) | −0.21 (−0.74, 0.32) | −0.23 (−0.65, 0.19) | ||||||||
<56a | ||||||||||||||||
Gender | 0.37 | 0.93 | 0.55 | 0.46 | 0.17 | 0.42 | 0.97 | 0.91 | ||||||||
Male | −0.19 (−0.62, 0.23) | 0.06 (−1.65, 1.77) | 0.12 (−0.26, 0.49) | −0.19 (−0.7, 0.31) | −0.5 (−1.21, 0.21) | −0.17 (−0.59, 0.25) | −0.01 (−0.49, 0.47) | 0.02 (−0.4, 0.45) | ||||||||
Femalea | ||||||||||||||||
Race | 0.78 | 0.61 | 0.91 | 0.73 | 0.74 | 0.23 | 0.31 | 0.87 | ||||||||
White | 0.09 (−0.55, 0.73) | −0.45 (−2.58, 1.68) | −0.03 (−0.59, 0.52) | 0.13 (−0.62, 0.88) | −0.17 (−1.21, 0.87) | 0.38 (−0.24, 1.01) | 0.41 (−0.43, 1.26) | 0.05 (−0.57, 0.68) | ||||||||
Non-whitea | ||||||||||||||||
Stage | 0.37 | 0.70 | 0.83 | 0.27 | 0.47 | 0.09 | 0.20 | 0.69 | ||||||||
III/IV | 0.2 (−0.23, 0.62) | 0.32 (−1.68, 2.31) | 0.04 (−0.35, 0.43) | 0.29 (−0.22, 0.81) | 0.28 (−0.49, 1.04) | 0.37 (−0.06, 0.81) | 0.36 (−0.21, 0.93) | −0.09 (−0.53, 0.35) | ||||||||
I/IIa | ||||||||||||||||
Tumour locat | 0.77 | 0.84 | 0.99 | 0.58 | 0.28 | 0.87 | 0.59 | 0.45 | ||||||||
Colon | −0.06 (−0.48, 0.36) | 0.14 (−1.54, 1.81) | 0 (−0.38, 0.37) | −0.14 (−0.65, 0.36) | 0.4 (−0.32, 1.12) | 0.04 (−0.39, 0.46) | 0.15 (−0.43, 0.72) | −0.16 (−0.59, 0.26) | ||||||||
Rectuma | ||||||||||||||||
Timepoint | 0.10 | 0.61 | 0.16 | 0.27 | 0.74 | 0.00 | 0.39 | 0.49 | ||||||||
Baselinea | ||||||||||||||||
6 Mo | −0.14 (−0.39, 0.1) | −0.07 (−1.09, 0.96) | 0.01 (−0.29, 0.31) | −0.13 (−0.41, 0.14) | 0.08 (−0.33, 0.49) | 0.03 (−0.22, 0.27) | 0.28 (−0.16, 0.73) | −0.02 (−0.36, 0.32) | ||||||||
12 Mo | −0.28 (−0.54, −0.02) | −0.49 (−1.5, 0.51) | 0.15 (−0.17, 0.47) | 0.04 (−0.25, 0.33) | 0.24 (−0.19, 0.66) | 0.12 (−0.13, 0.37) | 0.28 (−0.14, 0.7) | 0.23 (−0.13, 0.59) | ||||||||
24 Mo | 0.12 (−0.28, 0.51) | −0.31 (−1.8, 1.18) | 0.51 (0.05, 0.97) | 0.33 (−0.12, 0.79) | 0.08 (−0.49, 0.65) | 0.37 (−0.01, 0.74) | −0.02 (−0.65, 0.61) | 0.23 (−0.29, 0.75) |
Abbreviations: CI=confidence interval; P-val=P-value; locat=location; Mo=month. † miR203 analysis not done due to small sample size; miRNA measured in ln (normalised copies).
Reference.